BULLETIN ON NARCOTICS - Volume VI, 1954

Title

BULLETIN ON NARCOTICS - Volume VI, 1954

Sections

ABBREVIATIONS
NOTE
A
B
C
D
E
F
G
H
I
J
K
L
M
N
4 O
P
Q
R
S
T
U
V
W
X
Y

Details

Pages: 1 to 6
Creation Date: 1955/01/01

Full size image: 2 kB

BULLETIN ON NARCOTICS - Volume VI, 1954

INDEX

ABBREVIATIONS

ECOSOC
stands for "Economic and Social Council"
WHO
stands for "World Health Organization"
PCOB
stands for "Permanent Central Opium Board"
ICPC
stands for "International Criminal Police Commission"

NOTE

References in italics indicate the beginning and the end of the article cited, when it deals, in its entirety, with the subject under which it is placed.

A

Acedicone hydrochloride

Physical data, No. 1, p. 12

X-ray diffraction data, No. 2, p. 46 (fig. No. 1, p. 60)

Acetic anhydride

Commission on Narcotic Drugs (9th session), No. 3-4, pp. 71, 72

Acetoxyketobemidone ydrochloride

Physical data, No. 1, p. 16

X-ray diffraction data, No. 2, p. 46 (fig. No. 2, p. 60)

Acetylmethadol, d-α- and dl, lmethadylacetate hydrochloride

Physical data, No. 1, p. 13

Acts see also: Laws

Act of 26 May 1922 (Narcotic Drugs Import and Export Act), No. 1, p. 2

Dangerous Drugs Act of 1930 (India), No. 3, p. 1

Decree of 19 November 1948 and drug addiction in France, No. 2, p. 13

Harrison Narcotic Law, No. 1, p. 2, 4, 5

Marihuana Tax Act, No. 1, p. 2

Opium Act of 1857, No. 3, p. 1

Opium Act of 1878 (India), No. 3, p. 1

Opium and Revenue Laws Act, 1950 (India), No. 3-4, p. 1Addiction

Bibliography, No. 1, p. 56, 57

Commission on Narcotic Drugs (9th session), No. 3-4, pp. 73, 74

Legislation (District of Columbia, U.S.A.), No. 2, pp. 70-71

Medical and social aspects in France, No. 2, p. 1-17

National Research Council, No. 1, p. 44

Some aspects of the social medical problem as seen by the general practitioner, No. 2, pp. 21-22

Traffic in narcotics, No. 1, pp. 1-6

Treatment, No. 1, p. 4; No. 2, p. 19

Treatment, care and rehabilitation, No. 2, pp. 18-20

Afghanistan

Use of heroin discontinued, No. 1, p. 42

All-India Narcotics Board

Production of opium, No. 3-4, p. 1

American Medical Association

Treatment of drug addiction, No. 2, p. 19

Analysis

Conformational, applied to morphine derivatives, No. 1, pp. 32-38

Methods of, No. 1, p. 89 of opium for morphine, No. 2, pp. 29 et seq.Anslinger, H.J.

Commission on Narcotic Drugs (9th session), No. 3-4, p. 71

The traffic in narcotics, No. 1, pp. 1-6 (photo)

Apomorphine hydrochloride

Identification, X-ray diffraction (fig., p. 60)

Physical data, No. 1, p. 12

X-ray diffraction data, No. 2, p.6

Argentina

Commission on Narcotic Drugs (9th session),

No. 3-4, pp. 71, 74

Heroin production, No. 1, p. 41

Assay

Opium for morphine, No. 2, p. 23 et seq.

Asthana, S.N.

Cultivation of the opium poppy in India, No. 3-4, pp 1-10

Australia

Heroin consumption, No. 1, p. 42

Heroin, Use of, discontinued, No. 1, p. 42

B

Barnes, W.H.

Physical methods for the identification of narcotics, Part II A, No. 1, p. 20-31; Part II B, No. 2, pp. 27-68

Belgium

Heroin production, No. 1, p. 41

Benzylmorphine hydrochloride

X-ray diffraction data, No. 2, p. 46 (figs. Nos. 4, 5, p. 60)

Bibliography

Identification of narcotics, No. 1, p. 19

Morphine, Conformational analysis of, No. 1, p. 38

Morphine, Isolation and determination of, No. 2, p. 26

Scientific publications on narcotic drugs for 1953, No. 1, pp. 48-57

Synthetic drugs, No. 2, pp. 73-83; No. 3-4, pp. 77-87

Ultraviolet spectrophotometry, No. 3-4, pp. 39-41, 70

X-ray diffraction powder method, No. 1, pp. 31, 37

Bolivia

Coca leaves, No. 1, p. 40

Commission on Narcotic Drugs (9th session), No. 3-4, pp. 71, 74

Bulgaria

Raw opium production, No. 1, p. 39

The traffic in narcotics, No. 1, p. 1

Bureau of Narcotics, U.S.A.

Duties, No. 1, p. 3

Post-war addiction, No. 1, p. 5

Burma

Commission on Narcotic Drugs (9th session), No. 3-4, p. 71

C

Cambodia

Opium, non-medical consumption, No. 1, p. 40

1953 Protocol, No. 2, p. 69

Campaign

Anti-narcotics, No. 1, p. 4

Canada

Committee of Chemical Experts, No. 3-4, pp. 72, 73

Committee on Seizures, No. 3-4, p. 72

Drug addiction, No. 2, pp. 7-9

1953 Protocol, No. 2, pp. 69, 70

Cannabis (Indian hemp)

Bibliography, No. 1, p. 53

Commission on Narcotic Drugs (9th session), No. 3-4, p. 74

Drug addiction in France, No. 2, p. 9

Expert Committee (WHO), No. 1, p. 47 Legislation in Tunisia, No. 2, pp. 71-72

New single convention, No. 1, p. 2

PCOB Report (1953), No. 1, pp. 40, 43

Ceylon

Opium import, No. 1, p. 40

Chile

1953 Protocol, No. 2, p. 69

China

Committee of Chemical Experts, No. 3-4, p. 73

Illicit traffic, No. 3-4, p. 72

1953 Protocol, No. 2, pp. 69, 70

Chirrah (or Agiya)

Disease of the poppy, No. 3-4, p. 10

Chromatography

Determination of morphine in opium, No. 2, pp. 23.-26

Clinic plan

Traffic of narcotics, No. 1, pp. 5, 6Clinics

Report on narcotic clinics, No. 2, p. 19

Coca leaves

Bibliography, No. 1, p. 53

Commission on Narcotic Drugs (9th session), No. 3-4, pp. 74, 75

Expert Committee (WHO), No. 1, pp. 46, 47

New single convention, No. 1, p. 2

Report of the PCOB, No. 1, p. 40

Cocaine, hydrochloride

Addiction, No. 1, p. 5

Bibliography, No. 1, p. 53

Crude cocaine, No. 1, p. 40

Drug addiction in France, No. 2, p. 9

Identification, X-ray diffraction, data No. 2, p. 47 (figs. Nos. 6, 7, p. 60)

Physical data, No. 1, pp. 12, 17

Codeine

Brought under control, No. 1, p. 41

Conformational analysis of morphine derivatives, No. 1, pp. 33 et seq.

Content in Indian opium, No. 3-4, pp. 8, 9

Conversion into morphine, No. 1, pp. 39, 44

Manufactured from morphine, No. 1, p. 40

Physical data, No. 1, p. 12

X-ray diffraction, No. 2, pp. 29, 30, 38, 40, 42, 43, 44, 45, 47 (figs. Nos. 8, 9, 10, 11, pp. 60, 61; Nos. 84, 85, 86, p. 68)

Codeinone, dihydro, and dihydrohydroxy

Physical data, No. 1, p. 12

Colombia

Coca leaves, No. 1, p. 40

Commission on Narcotic Drugs (9th session), No 3-4, pp. 71, 75

Commission on Narcotic Drugs

Ninth session, No. 3-4, pp. 71-75

Commissioner of Narcotics

Control of narcotics in the U.S.A., No. 1, pp. 2, 3

Committee of Chemical Experts

Commission on Narcotic Drugs (9th session), No. 34, pp. 72, 73

Committee on Seizures

Commission on Narcotic Drugs (9th session), No. 3-4, p. 72

Conferences

Shanghai

Traffic in narcotics, No. 1, p. 2

1931 Conference

Use of heroin, No. 1, pp. 41, 42

Congress, USA

Control of narcotics, No. 1, pp. 2, 3

Control

Opium in Pakistan, No. 3-4, pp. 11 et seq.

PCOB report for 1953, No. 1, pp. 39-43;No. 3-4, p. 71 et seq.

Twenty-five years' retrospect, No. 1, pp. 42, 43

1925 Convention (Action under)

Commission on Narcotic Drugs (9th session),

No. 3-4, pp. 71, 72

Heroin consumption, No. 1, p. 42

Report of PCOB (1953), No. 1, p. 39

Retrospect, No. 1, pp. 42-43

1951 Convention (Action under)

Commission on Narcotic Drugs (9th session), No. 3-4, pp. 71, 72

Dithienylbutenylamines, No. 1, p. 46

Drug addiction, No. 2, p. 18

N-allylnormorphine, No. 1, p. 45

Report of PCOB (1953), No. 1, pp. 39, 42

Synthetics of methadone type, No. 1, pp. 45, 46

Convention, New single

Commission on Narcotic Drugs (9th session), No. 3-4, p. 73

The traffic in narcotics, No. 1, p. 1

Treatment of drug addicts, No. 2, p. 18

Conventions

The traffic in narcotics, No. 1, pp. 1, 2, 3

Costa Rica

1953 Protocol, No. 2, p. 69

Cotarnine

Physical data, No. 1, p. 12

X-ray diffraction, No. 2, pp. 31, 38, 40, 42, 43, 45, 48 (fig. No. 12, p. 61)

Cryptopine

Physical data, No. 1, p. 12

X-ray diffraction data, No. 2, p. 48 (fig. No. 13)

Curves

Spectral data, pp. 21, 27 et seq., 34, 35, 36, 43, 44, 50-63

Czechoslovakia

Use of heroin discontinued, No. 1, p. 42

D

Demerol, Dolosal, see: Pethidine

Denmark

1953 Protocol, No. 2, p. 69, 70

Desclaux, P., Derobert, L., Katz, R.F.

Aspect d'actualité des toxicomanies, No. 2, pp. 10, 13, 14

Dextrorphan, dextromethorphan hydrobromide

Expert Committee (WHO), No. 1, p. 46

Physical data, No. 1, p. 14

Diamorphine, diacetylmorphine, see: Heroin

Dihydrocodeine, dihydrocodeinone, bitartrate

X-ray diffraction data, No. 2, p. 48, 49 (fig. Nos. 16, 17, 18, p. 61)

Dihydromorphine

Nonaqueous titration, No. 1, p. 21

X-ray diffraction data, No. 2, p. 49 (fig. No. 19, p. 61)

Dihydromorphinone

Identification (X-ray diffraction), No. 2, p. 32, 33, 38, 40, 42, 43 et seq. (fig. No. 20, p. 61)

X-ray diffraction data, No. 2, p. 49

Dihydrooxycodeinone (Eucodal, Eubine, Pancodine)

Drug addiction in France, No. 2, p. 9

Dioxyline

Physical data, No. 1, p. 13

X-ray diffraction data, No. 2, p. 49 (fig. No. 21, p. 62)

Diseases of the poppy plant, No. 3-4, p. 9, 10

Dithienylbutenylamines

Bibliography, No. 1, pp. 55, 56; No. 3-4, p. 87

Expert Committee (WHO), No. 1, p. 46

Dominican Republic

1953 Protocol, No. 2, p. 69

Drug Supervisory Body

Estimates of World Requirements of Narcotic Drugs, No. 3-4, p. 72

E

East India Company

Opium trade, No. 3-4, p. 1

Ecgonine

Physical data, No. 1, p. 17

Economic and Social Council

Eighteenth session, No. 3-4, pp. 71-75

Ecuador

1953 Protocol, No. 2, p. 69

Egypt

Committee on seizures, No. 3-4, p. 72 1953 Protocol, No. 2, p. 69, 70

Ethiopia

Use of heroin discontinued, No. 1, p. 42

Ethyhmorphine

Conversion into morphine, No. 1, p. 44

Ethylmorphine hydrochloride

X-ray diffraction data, No. 2, pp. 38 et seq.,(fig. No. 22, p. 62)

Ethylnarceine hydrochloride

X-ray diffraction data, No. 2, pp. 49, 50 (fig. No. 23, p. 62)

Ethylpethidine hydrochloride

Physical data, No. 1, p. 16 X-ray diffraction data, No. 2, p. 50 (fig. No. 24, p. 62)

Eucodal, see Dihydrooxycodeinone

Expert Committee on Drugs liable to produce Addiction

International non-proprietary names, No. 1, p. 46; list of. No. 1, p. 47

Report (4th session), No. 1, pp. 44-47

Exports

Coca leaves, No. 1, p. 40 Opium, No. 1, p. 40

F

Farmilo, Charles G.

Comments on scientific research, No. 3-4, pp. 72, 73

Physical methods for the identification of narcotics, Part I B, No. 1, pp. 7-19; Part III A, No. 3, pp. 18-41; Part III B, No. 3, pp. 42, 70

Finland

Heroin consumption, No. 1, p. 42

France

Heroin production, No. 1, p. 41 Indian hemp

Legislation in Tunisia, No. 2, pp. 71-72 Morphine production, No. 1, p. 40 Opium monopolies, No. 1, p. 2 1953 Protocol, No. 2, pp. 69, 70 The traffic in narcotics, No. 1, p. 1

G

Gassner, S. see: Grosfeld-Nir, I.

Germany, Federal Republic of Commission on Narcotics Drugs (9th session), No. 3-4, p. 71

Heroin, Abolish use of, No. 1, p. 42 Heroin production, No. 1, p. 41 Morphine production, No. 1, p. 40 1953 Protocol, No. 2, p. 69

Ginsburg, David

The application of conformational analysis to morphine derivatives, No. 1, pp. 32-38

Goldstein, N. L.

Drug addiction. Treatment, care and rehabilitation, No. 2, pp. 18-20

Gourion, Dr.

Drug addiction in France, No. 2, pp. 10, 11Greece

Committee of Chemical Experts, No. 3-4, pp. 72, 73

Committee on Seizures, No. 3-4, p. 721948 Protocol and 1953 Protocol, No. 2, p. 69

Grosfeld-Nir, I., Gassner, S. and Weissenberg, E. A quantitative method for the isolation and determination of morphine in opium and medicinal preparations, No. 2, pp. 23-26

H

Hanswalt Index

X-ray diffraction (Identification), No. 2, pp. 41-68

Hashish see: Cannabis sativa

Hayat, J. F.

Morphinomanes et morphiniques, No. 2, pp. 13, 14

Heroin (diacetylmorphine, diamorphine)

Abolition of use, No. 1, pp. 41, 42 Bibliography, No. 1, pp. 51, 52 Commission on Narcotics Drugs (9th session), No. 3-4, pp. 71, 72, 74

Consumption, No. 1, p. 42 Drug addiction in France, No. 2, pp. 1 et seq.Heroin in the USA, No. 1, p. 3 Manufacture, No. 1, p. 41 Teenagers, No. 1, p. 5 WHO (6th Assembly), No. 1, p. 45 X-ray Diffraction, No. 2, pp. 31, 32, 38, 40, 42, 43, 44, 48 (fig. Nos. 14, 15, p. 61)

Hungary

Heroin production, No. 1, p. 41 Morphine production, No. 1, p. 40

Hydrastinine, hydrochloride monohydrate

X-ray diffraction data, No. 2, p. 50 (fig. No. 25, p. 62)

Hydrocodone bitartrate

Physical data, No. 1, p. 12

Hydromorphone, hydrochloride

Physical data, No. 1, p. 15

Hydroxypethidine hydrochloride

Physical data, No. 1, p. 16 X-ray diffraction data, No. 2, p. 50 (figs. Nos. 26, 27, p. 62)

I

Iceland

Use of heroin discontinued, No. 1, p. 42 Identification

Physical methods for the identification of narcotics, Part I B, No. 1, pp. 7-19; Part II A, No. 1, pp. 20-31

Spectrophotometric, No. 3, p. 26

Tables

Absorption maxima, by wave-lengths, No. 3-4, p. 46; chemical families, pp. 64-66 Csoskan, No. 3-4, p. 32 Formula index, No. 3-4, pp. 68-69 Morgan, No. 3-4, p. 33 Name index, No. 3-4, pp. 67-69

Illicit traffic

Commission on Narcotic Drugs (9th session), No. 3-4, pp. 71-72

Pakistan, No. 3-4, p. 15

PCOB Report (1953), No. 1, pp. 42-43

The traffic in narcotics, No. 1, pp. 1-6

Index of narcotics

Alphabetical (X-ray diffraction data), No. 2, pp. 38-39

Figures (X-ray diffraction), No. 2, pp. 59-68 Innermost line, No. 2, p. 40

Numerical (Hanawalt), No. 2, pp. 40-46 Tabulated (d, I/Ii) data, No. 2, pp. 46-58

India

Committee on Seizures, No. 3-4, p. 72 Cultivation of opium poppy in India, No. 3-4, pp. 1-10

Export of opium, No. 1, p. 40 1953 Protocol, No. 2, pp. 69, 70 Raw opium production, No. 1, p. 39

Indian hemp see: Cannabis sativa

Indonesia

Coca leaves, No. 1, p. 40Use of heroin discontinued, No. 1, p. 42

Instruments

Beckman spectrophotometer, No. 3-4, pp. 23, 24 (ill.), 25

Spectrophotometer, No. 3-4, p. 20 (ill.) Spekker photometer, No. 3-4, p. 22 (ill.)

Internal Revenue, USA

Control of narcotics, No. 1, pp. 2, 3

International Confederation of Free Trade Unions

Commission on Narcotic Drugs (9th session), No. 3-4, p. 71

International Conference of Catholic Charities Commission on Narcotic Drugs (9th session), No. 3-4, p. 71

International Criminal Police Commission Commission on Narcotic Drugs (9th session), No. 3-4, p. 71

International Federation of Women Lawyers Commission on Narcotic Drugs (9th session), No. 3-4, p. 71

Illicit traffic, No. 3-4, p. 72

Iran

Export of opium, No. 1, p. 40 1953 Protocol, No. 2, p. 69 Raw opium production, No. 1, p. 39 Use of heroin discontinued, No. 1, p. 42

Iraq

1953 Protocol, No. 2, p. 69

Ireland

1948 Protocol, No. 2, p. 69

Isomethadone, dl-, hydrochloride Physical data, No. 1, p. 13 X-ray diffraction data, No. 2, p. 50 (fig. No. 28, p. 62)

Israel

1953 Protocol, No. 2, p. 69

Italy

Commission on Narcotic Drugs (9th session), No. 3-4, p. 71

Heroin consumption, No. 1, p. 42 Heroin production, No. 1, p. 41 Illicit traffic, No. 3-4, p. 72 Morphine production, No. 1, p. 40 1953 Protocol, No. 2, p. 69

J

Japan

Commission on Narcotic Drugs (9th session), No 3-4, p. 71.

Morphine production, No. 1, p. 40

Japan ( continued)

Occupied territories, No. 1, p. 2

1953 Protocol, No. 2, pp. 69, 70

Jordan

Use of heroin discontinued, No. 1, p. 42

Josie, Gordon H.

A report on drug addiction in Canada, No. 2, p. 7-9

Juvenile delinquency

Traffic in narcotics, No. 1, p. 5

K

Ketobemidone hydrochloride

Physical data, No. 1, p. 16

X-ray diffraction data, No. 2, pp. 50, 51 (figs. Nos. 29, 30, p. 62)

Kif see: Cannabis sativa

Korea, Republic of

1953 Protocol, No. 2, p. 70

Krishnamoorthy, E. S.

Commission on Narcotic Drugs (9th session), No. 3-4, p. 71

L

Laos and Vietnam

Commission on Narcotic Drugs (9th session), No. 3-4, p. 71

Non-medical consumption, No. 1, p. 40

Raw opium production, No. 1, p. 39

Use of heroin discontinued (Laos), No. 1, p. 42

Laudanine, dl-

Physical data, No. 1, p. 14

X-ray diffraction data, No. 2, p. 51 (fig. No. 31 p. 63)

Laudanum

Drug addiction in France, No. 2, p. 9

Laws (Legislation)

National legislations (1952), No. 2, pp. 69-72

Synthetic drugs, No. 1, p. 44

League of Nations

Advisory Committee

Morphine production, No. 1, p. 42

Traffic in narcotics, No. 1, pp. 1-6

Supervisory Body

Traffic in narcotics, No. 1, p. 1

Lebanon

Commission on Narcotic Drugs (9th session), No. 3-4, p. 71

1953 Protocol, No. 2, p. 69

Legal trade in 1952, No. 1, pp. 39-43

Le Guillant

Les toxicomanies, No. 2, p. 14

Leriche, Professor

La chirurgie de la douleur, No. 2, p. 12

Levi, Leo

Physical methods for the identification of narcotics, Part I B, No. 1, pp. 7-19; Part III B, No. 3-4, pp. 42-70

Levorphan tartrate

Physical data, No. 1, p. 14

Lexington Hospital

Treatment of addicts, No. 1, p. 6; No. 2, p. 17

Liang, Dr.

Comments on scientific research, No. 3-4, p. 72, 73

Liechtenstein

1953 Protocol, No. 2, p. 69

Luxembourg

1948 Protocol, No. 2, p. 69

M

Meyran García, S. see : Sodi Pallares, E.

Marihuana see: Cannabis sativa

Mayoral Pardo, Prof. D.

Drug addiction. Some aspects of the social medical problem as seen by the general practitioner, No. 2, pp. 21-22

Meconic acid

Meconic acid trihydrate, X-ray diffraction data, No. 2, p. 51 (fig. No. 32, p. 63)

Physical data, No. 1, p. 17

Mescaline

Bibliography, No. 1, p. 57

Identification (X-ray diffraction), No. 2, pp. 33, 39, 40 et seq. (fig., p. 63)

Mescaline sulfate, Physical data, No. 1, p. 15

Mescaline sulfate dihydrate, X-ray diffraction data, No. 2, p. 51

Methadone

Addiction treatment, No. 1, p. 4

Bibliography, No. 1, p. 55; No. 3-4, pp. 77-83

Methadone, d-,dl-methadone, l-methadone hydrobromide, hydrochloride, Physical data, No. 1, p. 12

Expert Committee (WHO), also on metha-done-like substances, No. 1, p. 45, 46

Identification (X-ray diffraction), No. 2, p. 33, 39, 40, 42 et seq. (figs. Nos. 34, 35, 36, 37, p. 63)

Methods

Quantative method re: morphine, No. 2, pp. 23-26

Ultraviolet spectrophotometric method, No. 3-4, p. 18-41; Review No. 3-4, p. 26-34

X-ray diffraction, No. 2, pp. 27-68

Methorphan, dl- dl-Methorphan, d- and l-, hydrobromide monohydrate, dihydrate

X-ray diffraction data, No. 2, p. 52 (figs. Nos. 38, 39, 40, p. 63)

Methopon hydrochloride

Identification (X-ray diffraction), No. 2, pp. 34, 39, 40 et seq. (fig., p. 64)

Physical data, No. 1, p. 15

X-ray diffraction data, No. 2, pp. 52, 53 (figs. Nos. 43, 44, p. 46)

Methylketobemidone hydrochloride

Physical data, No. 1, p. 16

X-ray diffraction data, No. 2, p. 52 (figs. Nos. 41, 42, p. 64)

6-methyl- Δ 6 e-desoxymorphine

Expert Committee (WHO), No. 1, p. 45

Mexico

Adulteration of Mexican opium, No. 3-4, p. 16-17

Monaco

1953 Protocol, No. 2, p. 69

Monoacetylmorphine, α-

X-ray diffraction data, No. 2, p. 53 (fig. No. 45, p. 64)

Monopolies

Opium monopoly in India, No. 3-4, p. 1

Opium production, No. 1, p. 39

United States, No. 1, p. 2

Morphinan

Bibliography, No. 1, p. 55, No. 3-4, pp. 84-87

Physical data, No. 1, p. 13

Substances of morphinan type, No. 1, p. 46

Morphine

A quantitative method for the isolation and determination of morphine in opium and medicinal preparations, No. 2, pp. 23-26

Application of conformational analysis to morphine derivatives, No. 1, pp. 32-38

Bibliography, No. 1, pp. 50, 51; No. 3-4, pp. 84-87 (morph. synthesis)

Characterization from structure, No. 1, p. 44

Content in Indian opium, No. 3-4, pp. 5, 8, 9,10

Conversion of codeine, ethylmorphine, No. 1, p. 44

Drug addiction in France, No. 2, pp. 1 et seq.

Identification (X-ray diffraction), No. 2, pp. 34, 39, 40 et seq. (fig., pp. 64-65) in the U.S.A., No. 1, p. 3

Manufacture, No. 1, pp. 40, 41, 42

Manufactured from poppy straw, No. 1, p. 40

Physical data, No. 1, pp. 14, 15 (dihydro, ethyl, α-monoacetyl, etc.)

Retard preparations, No. 1, pp. 44, 45

X-ray diffraction data, No. 2, pp. 53, 54: (figs. Nos. 46-53, pp. 64, 65)

Morphinone

Physical data, No. 1, p. 15

Morphothebaine hydrochloride

Physical data, No. 1, p. 15

X-ray diffraction data, No. 2, p. 54 (fig. No. 54, p. 65)

N

N-allylnormorphine (Nalorphine), diacetyl-N-allylnormorphine hydrochloride

Expert Committee (WHO), No. 1, p. 45

Physical data, No. 1, p. 15

X-ray diffraction data, No. 2, pp. 54, 55 (fig. No. 5, p. 65)

Narceine

Physical data, No. 1, p. 15

X-ray diffraction data, No. 2, p. 55 (fig. No. 56, p. 65)

Narcotine, hydrochloride

Content in Indian Opium, No. 3-4, p. 8, 9

Identification (X-ray diffraction), No. 2, p. 35, 39, 40, 41 et seq. (figs., Nos. 57-60, p. 65)

Physical data, No. 1, p. 15

National Research Council, U.S.A.

Drug addiction, No. 1, p. 44

Neopine hydrobromide

Physical data, No. 1, p. 15

X-ray diffraction data, No. 2, p. 55 (fig. No. 61, p. 66)

Netherlands

Opium monopolies, No. 1, p. 2

1953 Protocol, No. 2, p. 69

The traffic in narcotics, No. 1, p. 1

New Zealand

Heroin consumption, No. 1, p. 42

1953 Protocol, No. 2, p. 70

Nomenclature

International non-proprietary names, No. 1, p. 46 (WHO)

- Listed by Expert Committee (WHO), No. 1, p. 47

- Non-proprietary, trade and chemical names, No. 1, pp. 17-19

4 O

Oestreicher, Pamela M.

Physical methods for the identification of narcotics, Part I B, No. 1, pp. 7-19;Part III B, No. 3-4, pp. 42-70

Opianic acid

X-ray diffraction data, No. 2, pp. 55, 56 (fig. No. 62, p. 66)

Opium

Adulteration of Mexican opium, No. 3-4, pp. 16-17

Bibliography, No. 1, p. 50

Morphine content, No. 2, pp. 23-26

Opium in Pakistan, No. 3-4, pp. 11-15

Raw opium production, No. 1, p. 39

Research on origin, No. 3-4, pp. 72, 73

Traffic in narcotics, No 1, pp. 1-6

Opium poppy

Bibliography, No. 1, p. 50

Cultivation of the opium poppy in India, No. 3-4, pp. 1-10

Opium-smoking

Drug addiction in France, No. 2, p. 9

Illegal, No. 1, p. 2

Pakistan, No. 3-4, p. 13

Orphan hydrobromide, dl-, d- and l- tartrate dihydrate

X-ray diffraction data, No. 2, p. 56 (figs. Nos. 63, 64, 65, p. 66)

Oxycodone hydrochloride

Physical data, No. 1, p. 12

X-ray diffraction data, No. 2, p. 56 (fig. No. 66, p. 66)

P

Pakistan

Map, No. 3-4, p. 14

Opium imports, No. 1, p. 40

Opium in Pakistan, No. 3-4, pp. 11-15

1948 Protocol, No. 2, p. 69

1953 Protocol, No. 2, p. 70

Panama

1953 Protocol, No. 2, p. 70

Use of heroin discontinued, No. 1, p. 42

Panopoulos, Dr.

Comments on scientific research, No. 3-4, pp. 72, 73

Papaver

Species and varieties, No. 3-4, pp. 2, 3, 4, 5 (ill.)

Papaverine hydrochloride

Physical data, No. 1, pp. 13, 14

X-ray diffraction data, No. 2, pp. 56, 57 (figs. Nos. 68, 69, p. 66)

X-ray diffraction powder patterns, No. 1, p. 28

Pax Romana

Commission on Narcotics Drugs (9th session), No. 3-4, p. 71

Penalties

Traffic in narcotics, No. 1, pp. 2, 3, 4, 5

Permanent Central Opium Board

1953 Report, No. 1, pp. 39-43; No. 3-4, pp. 72-75

Peru

Coca leaves, No. 1, p. 40

Pests of the poppy plant, No. 3-4, pp. 9, 10

Pethidine (Dolosal, Demerol) hydrochloride

Bibliography, No. 1, pp. 54, 55

Drug addiction in France, No. 2, p. 9

Identification, No. 2, pp. 36, 39, 40, 42 et seq. (fig. No. 71, p. 67 (X-ray diffraction))

Physical data, No. 1, p. 16

X-ray diffraction data, No. 2, p. 57

Phanadoxone, hydrochloride

Physical data, No. 1, p. 13

X-ray diffraction data, No. 1, p. 57 (figs. Nos. 72, 73, p. 67)

Philippines

1953 Protocol, No. 2, p. 70

Physical data, names and formulas

- tabulated, No. 1, pp. 12-17

Physicians

Control of narcotics, No. 1, pp. 2, 3

Piperidine

Physical data, No. 1, p. 15

Pipidone hydrochloride

Physical data, No. 1, p. 13

X-ray diffraction data, No. 2, p. 57 (fig. No. 74, p. 67)

Poland

Comments on illicit traffic, No. 3-4, p. 72

Poppy straw

Manufacture of morphine, No. 1, p. 40 Portugal

Opium monopolies, No. 1, p. 2

Prodine, alpha, beta, dl-, hydrochloride

Identification (X-ray diffraction), No. 2, pp. 36, 39, 40, 42 et seq. (fig., pp. 67, 68)

Physical data, No. 1, p. 15

X-ray diffraction data, No. 2, pp. 57, 58 (figs. Nos. 75, 76, p. 67)

Propylketobemidone

X-ray diffraction data, No. 2, p. 58 (fig. No. 77, p. 67)

Protocol, 1948

Accepted by various countries, No. 2, p. 69

Synthetic drugs control, No. 1, pp. 42, 43

Protocol, 1953

Commission on Narcotic Drugs (9th session), No. 3-4, p. 73

Ratified, No. 2, p. 70

Signed by various countries, No. 2, pp. 69, 70

Protopine

Identification (X-ray diffraction), No. 2, pp. 36, 40, 43 et seq. (fig. No. 78, p. 67)

Physical data, No. 1, p. 16

Pseudomorphine trihydrate

Physical data, No. 1, p. 16

X-ray diffraction data, No. 2, p. 58 (fig. No. 79, p. 67)

Pyrahexyl

Physical data, No. 1, p. 17

Q

Quasi-medical use

Pakistan, No. 3-4, p. 11

R

Racemethorpan hydrobromide

Physical data, No. 1, p. 14

Racemorphan hydrobromide

Physical data, No. 1, p. 14

Raw materials

New single convention, No. 1, p. 2

Raw Opium

see: Opium

Report

Annual reports, No. 34, p. 71

Commission on Narcotic Drugs to ECOSOC, No. 3-4, pp. 71 et seq. on narcotic clinics, No. 2, p. 19

Permanent Central Opium Board, No. 1, pp. 39-43, No. 3-4, pp. 72-75

Resolutions

ECOSOC on synthetic drugs, No. 1, p. 44 436 (XIV) G (ECOSOC), No. 1, p. 45

Russell Pasha (Sir Thomas Wentworth)

Obituary, No. 3-4, p. 76

S

Saudi Arabia

Use of heroin discontinued, No. 1, p. 42

Sheppard, Helen M.

Physical methods for the identification of narcotics, Part II B, No. 2, pp. 27-68

Sinomenine

Physical data, No. 1, p. 17

X-ray diffraction data, No. 2, p. 58 (fig. No. 80, p. 67)

Sodi Pallares, E.; S. Meyran García

Adulteration of Mexican opium, No. 3-4, pp. 16-17

South Korea

Use of heroin discontinued, No. 1, p. 42

Spain

1953 Protocol, No. 2, p. 70

Spectra

Absorption curves, tables, No. 3-4, pp. 28, 29 et seq.

Influence of pH, tables, No. 3-4, pp. 36, 37, 38, 39

Quantitative spectrometry, No. 3-4, p. 34

Ultraviolet spectral data for ninety narcotics and related compounds, No. 3-4, pp. 42-70

Ultraviolet spectrophotometric method, No. 3-4, pp. 18-41

Statistics

Drug addiction in France, No. 2, pp . 1-17; in Canada, No. 2, pp. 7-9

Stern, G.; Ch. Vaille

Drug addiction, medical and social aspects in France, No. 2, pp. 1-17

Supervisory Body

Question of heroin, No. 1, pp. 41-42

Sweden

Heroin, Abolish use of, No. 1, p. 42 consumption, No. 1, p. 42 production, No. 1, p. 41

Switzerland

Commission on Narcotic Drugs (9th session), No. 3-4, p. 71

Dexrorphan and dextromethorphan, No. 1, p. 46

Morphine production, No. 1, p. 40

1948 Protocol, No. 2, p. 69

1953 Protocol, No. 2, p. 70

The traffic in narcotics, No. 1, p. 1

Synthetic drugs

Bibliography, No. 1, pp. 54-56; No. 2, pp. 73-83

Commission on Narcotic Drugs (9th session), No. 3-4, p. 74

Expert Committee (WHO), No. 1, pp. 44, 45, 46

Illicit traffic, No. 3-4, p. 72

Synthetic drugs ( continued)

Legislation in 1952, No. 2, pp. 69-72

New single convention, No. 1, p. 2

1948 Protocol, No. 1, pp. 42, 43

T

Tables

Absorbency (Morgan), No. 3-4, p. 33

Absorption maxima, minima (Elvidge), No 3-4, p. 37

Absorption, by wave-lengths, No. 3-4, p. 46

Beckman spectrophotometer, No. 3-4, p. 25

Effect of pH on absorption maxima, No. 3-4, p. 37

Formula index for spectra, No. 3-4, pp. 68-69

Key-points in absorption spectra (Edwards), No. 3-4, p. 39

Name index for ultra-violet spectra, No. 3-4, pp. 67-68

Relation of concentration to absorbency, No. 3-4, p. 39

Spectral data, by chemical families, No. 3-4, pp. 64-66

Spectrophotometric data (Csoskan), No. 3-4 p. 32

Takrouri see: Cannabis sativa

Thailand

Commission on Narcotic Drugs (9th session), No.3-4, p. 71

Non-medical consumption, No. 1, p. 40

Opium-smoking, No. 1, p. 2

Use of heroin discontinued, No. 1, p. 42

Thebaine hydrochloride

Physical data, No. 1, p. 17

X-ray diffraction data, No. 2, p. 58 (figs. Nos. 81, 82, p. 68)

Thebenine, hydrochloride monohydrate

Identification (X-ray diffraction), No. 2, pp. 37, 39, 40, 42 et seq. (fig. No. 83, p. 68)

Physical data, No. 1, p. 17

Tompkins, W. F.

The traffic in narcotics, No. 1, pp. 1-6 (photo)

Treaties, Conventions

The traffic in narcotics, No. 1, pp. 1-6

Trichocereine hydrochloride

Physical data, No. 1, p. 15

Turkey

Committee on Seizures, No. 3-4, p. 72

1953 Protocol, No. 2, p. 70

Raw opium production, No. 1, p. 39

Use of heroin discontinued, No. 1, p. 42

U

Ultraviolet

Absorption spectrophotometry (review), No. 3-4, pp. 26-34

Influence of pH, No. 3-4, pp. 36, 37, 38

Quantitative spectrophotometry, No. 3-4, pp. 34, 35, 36

Spectral data for 90 narcotics and related compounds, No. 3-4, pp. 42-70

Union of South Africa

Commission on Narcotic Drugs (9th session), No. 3-4, p. 71

1953 Protocol, No. 2, p. 70

Use of heroin discontinued, No. 1, p. 42

Union of Soviet Socialist Republics

Convention, Illicit Traffic, No. 3-4, p. 72

Morphine production, No. 1, p. 40

Raw opium production, No. 1, p. 39

Use of heroin discontinued, No. 1, p. 42

United Kingdom

Committee on Seizures, No. 3-4, p. 72

Heroin consumption, No. 1, p. 42

Heroin production, No. 1, p. 41

Morphine production, No. 1, p. 40

Opium monopolies, No. 1, p. 2

1953 Protocol, No. 2, p. 70

United States of America

Committee on Seizures, No. 3-4, p. 72

Control of narcotics, No. 1, p. 2

Dithienylbutenylamines, No. 1, p. 46

Legislation on addiction, No. 2, pp. 70-71

Methadone-like substances, No. 1, pp. 45, 46

Morphinan-type substances, No. l, p. 46

N-allylnormorphine, No. 1, p. 45; 6-methyldesoxymorphine and diacetyl-N-allylnormorphine, No. 1, p 45

1953 Protocol, No. 2, p. 70

The traffic in narcotics, No. 1, pp. 1-6;No. 3-4, p. 72

Treatment of addicts, No. 2, pp. 18 et seq.

V

Vaille, C.

Drug addiction, Medical and social aspects in France, No. 2, pp. 1-17

Commission on Narcotic Drugs (9th session), No. 3-4, p. 71

Venezuela

1953 Protocol, No. 2, p. 70

Viet-Nam

Commission on Narcotic Drugs (9th session,) No. 3-4, p. 71

1953 Protocol, No. 2, p. 70

Vogel, Dr. V. H.

Drug addiction in France, No. 2, pp. 16, 17

W

Weissenberg, E. see: Grosfeld-Nir, I.

WHO

Question of heroin, No. 1, pp. 41-42

Withdrawal

Methadone, No. 1, p. 4

Treatment of drug addicts, No. 1, p. 18

Wolff, P. O.

Eumorphine, No. 2, p. 22

Quelques aspects actuels de la toxicomanie, No. 2, p. 15

World Federation of Trade Unions

Commission on Narcotic Drugs (9th session), No. 3-4, p. 71

World Health Organization (WHO)

Commission on Narcotic Drugs, No. 3-4, p. 71

Drug addiction, No. 3-4, pp. 73, 74

Report, No. 3-4, p. 72

World Union for Progressive Judaism

Commission on Narcotic Drugs (9th session), No. 3-4, p. 71

World's Alliance of YMCA

Commission on Narcotic Drugs (9th session), No. 3-4, p. 71

Wright, A. E.

Opium in Pakistan, No. 3-4, pp. 11-15

X

The X-Ray diffraction powder method

Data, No. 2, pp. 27-68

Identification of narcotics, No. 1, pp. 20-31

Y

Yield

Morphine, codeine, narcotine in Indian poppies, No. 3, pp. 8, 9, 10

Opium in poppies (India), No. 3-4, pp. 2, 3

Opium (Pakistan), No. 3-4, pp. 12, 13

Yugoslavia

Morphine production, No. 1, p. 40

1952 Protocol, No. 2, p. 70

Raw opium production, No. 1, p. 39

The traffic in narcotics, No. 1, p. 1

Use of heroin discontinued, No. 1, p. 42